Matthew J Kempton
Overview
Explore the profile of Matthew J Kempton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
3723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ader L, Schick A, Vaessen T, Morgan C, Kempton M, Valmaggia L, et al.
Schizophr Bull
. 2024 Feb;
50(4):891-902.
PMID: 38366989
Background And Hypotheses: Affective recovery, operationalized as the time needed for affect to return to baseline levels after daily stressors, may be a putative momentary representation of resilience. This study...
12.
Si S, Bi A, Yu Z, See C, Kelly S, Ambrogi S, et al.
Mol Psychiatry
. 2024 Jan;
29(2):496-504.
PMID: 38195979
Introduction: Regional gray matter (GM) alterations have been reported in early-onset psychosis (EOP, onset before age 18), but previous studies have yielded conflicting results, likely due to small sample sizes...
13.
Blackman G, Kempton M, McGuire P
JAMA Psychiatry
. 2023 Nov;
81(1):109.
PMID: 37966847
No abstract available.
14.
Merritt K, Laguna P, Sethi A, Drakesmith M, Ashley S, Bloomfield M, et al.
Mol Psychiatry
. 2023 Oct;
28(9):3688-3697.
PMID: 37903876
Psychotic experiences (PEs) occur in 5-10% of the general population and are associated with exposure to childhood trauma and obstetric complications. However, the neurobiological mechanisms underlying these associations are unclear....
15.
Acute effects of mifepristone on emotional processing related brain activity: A functional MRI study
Yalin N, Kempton M, Mazibuko N, Mehta M, Young A, Stokes P
Eur Neuropsychopharmacol
. 2023 Sep;
77:93-102.
PMID: 37742397
The Hypothalamic-pituitary-adrenal (HPA) axis plays an important role in the pathophysiology of mood disorders, and preliminary data suggests that glucocorticoid receptor (GR) antagonism may be an important therapeutic mechanism. The...
16.
Blackman G, Neri G, Al-Doori O, Teixeira-Dias M, Mazumder A, Pollak T, et al.
JAMA Psychiatry
. 2023 Jul;
80(10):1047-1054.
PMID: 37436735
Importance: Individuals presenting with first-episode psychosis (FEP) may have a secondary ("organic") etiology to their symptoms that can be identified using neuroimaging. Because failure to detect such cases at an...
17.
Olah J, Diederen K, Gibbs-Dean T, Kempton M, Dobson R, Spencer T, et al.
Schizophr Res
. 2023 Apr;
259:11-19.
PMID: 37080802
Background: Remote assessment of acoustic alterations in speech holds promise to increase scalability and validity in research across the psychosis spectrum. A feasible first step in establishing a procedure for...
18.
Chester L, Valmaggia L, Kempton M, Chesney E, Oliver D, Hedges E, et al.
Psychiatry Clin Neurosci
. 2023 Apr;
77(9):469-477.
PMID: 37070555
Aims: Evidence for case-control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this...
19.
Mondelli V, Blackman G, Kempton M, Pollak T, Iyegbe C, Valmaggia L, et al.
Brain Behav Immun
. 2023 Mar;
110:290-296.
PMID: 36940754
Individuals at clinical high risk (CHR) for psychosis have been found to have altered cytokine levels, but whether these changes are related to clinical outcomes remains unclear. We addressed this...
20.
Tognin S, Catalan A, Kempton M, Nelson B, McGorry P, Riecher-Rossler A, et al.
Eur Psychiatry
. 2023 Jan;
66(1):e16.
PMID: 36649929
Background: Adverse childhood experiences (ACE) can affect educational attainments, but little is known about their impact on educational achievements in people at clinical high risk of psychosis (CHR). Methods: In...